UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Annals of oncology, 2006-05, Vol.17 (5), p.866-873

2006

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer

International journal of clinical pharmacology and therapeutics, 2004-11, Vol.42 (11), p.650

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

International journal of clinical pharmacology and therapeutics, 2003-12, Vol.41 (12), p.620

2003

Link zum Volltext

Verfügbarkeit prüfen

Connexin26 und -30 im Innenohr und ihre klinische Bedeutung

Laryngo- rhino- otologie, 2001, Vol.80 (12), p.719-724

2001

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population

Human mutation, 2001-06, Vol.17 (6), p.521-522

2001

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3049-3049

2004

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3049-3049

2004

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase I trial of BAY 43–9006 in combination with oxaliplatin in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3056-3056

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase I dose-escalation trial with the new redox activated compound sodium trans -[tetrachlorobis(1 H -indazole)ruthenate(III)]/indazolhydrochloride (1:1.1) (FFC14A) in patients with solid tumors - a CESAR study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2101-2101

2004

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase I trial of BAY 43–9006 in combination with oxaliplatin in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3056-3056

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase I dose-escalation trial with the new redox activated compound sodium trans -[tetrachlorobis(1 H -indazole)ruthenate(III)]/indazolhydrochloride (1:1.1) (FFC14A) in patients with solid tumors - a CESAR study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2101-2101

2004

Link zum Volltext

Verfügbarkeit prüfen

Connexin26 and -30 in the Cochlea and their clinical relevance

Laryngo- rhino- otologie, 2001-12, Vol.80 (12), p.719-724

2001

Link zum Volltext

Verfügbarkeit prüfen

Connexin26 und -30 im Innenohr und ihre klinische Bedeutung

Laryngo- rhino- otologie, 2001-12, Vol.80 (12), p.719-724

2001

Link zum Volltext

Verfügbarkeit prüfen

Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years

Journal of neurology, 2020-06, Vol.267 (6), p.1622-1631

2020

Link zum Volltext

Verfügbarkeit prüfen

Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease

The European journal of neuroscience, 2006-04, Vol.23 (7), p.1956-1960

2006

Link zum Volltext

Verfügbarkeit prüfen

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial

Lancet neurology, 2014-09, Vol.13 (9), p.875-884

2014

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years

Journal of neurology, 2022, Vol.269 (1), p.540-540

2022

Link zum Volltext

Verfügbarkeit prüfen

Cortico-cortical coupling in Parkinson's disease and its modulation by therapy

Brain (London, England : 1878), 2005-06, Vol.128 (6), p.1277-1291

2005

Link zum Volltext

Verfügbarkeit prüfen

Three-dimensional study of compressed gas diffusion layers using synchrotron X-ray imaging

Journal of power sources, 2014-05, Vol.253, p.123-131

2014

Link zum Volltext

Verfügbarkeit prüfen

Isotopenpraxis

Mühlenpfordt, J

2023

Link zum Volltext

Verfügbarkeit prüfen

In situ analysis of damage evolution in an Al/[Formula omitted] MMC under tensile load by synchrotron X-ray refraction imaging

Journal of materials science, 2018-04, Vol.53 (8), p.6021-6032

2018

Link zum Volltext

Verfügbarkeit prüfen

The agony of choice in dermatophyte diagnostics—performance of different molecular tests and culture in the detection of Trichophyton rubrum and Trichophyton interdigitale

Clinical microbiology and infection, 2016-08, Vol.22 (8), p.735.e11-735.e17

2016

Link zum Volltext

Verfügbarkeit prüfen

Dopamine depletion increases the power and coherence of β-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat

The European journal of neuroscience, 2005-03, Vol.21 (5), p.1413-1422

2005

Link zum Volltext

Verfügbarkeit prüfen

Event‐related beta desynchronization in human subthalamic nucleus correlates with motor performance

Brain (London, England : 1878), 2004-04, Vol.127 (4), p.735-746

2004

Link zum Volltext

Verfügbarkeit prüfen

The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease

Experimental neurology, 2005-07, Vol.194 (1), p.212-220

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(162)
Deutsch
(16)
Japanisch
(15)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(68)
Humans
(53)
Male
(52)
Neurosciences & Neurology
(52)
Female
(48)
Middle Aged
(41)
Neurosciences
(40)
Neurology
(39)
Biological And Medical Sciences
(34)
Aged
(31)
Medical Sciences
(30)
Clinical Neurology
(27)
Parkinson's Disease
(26)
Technology
(25)
Adult
(24)
Parkinson Disease - Physiopathology
(21)
Materials Science
(19)
Physical Sciences
(19)
Subthalamic Nucleus
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

Connexin26 und -30 im Innenohr und ihre klinische Bedeutung

Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population

Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors

Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors

Results of a phase I trial of BAY 43–9006 in combination with oxaliplatin in patients with refractory solid tumors

A phase I dose-escalation trial with the new redox activated compound sodium trans -[tetrachlorobis(1 H -indazole)ruthenate(III)]/indazolhydrochloride (1:1.1) (FFC14A) in patients with solid tumors - a CESAR study

Results of a phase I trial of BAY 43–9006 in combination with oxaliplatin in patients with refractory solid tumors

A phase I dose-escalation trial with the new redox activated compound sodium trans -[tetrachlorobis(1 H -indazole)ruthenate(III)]/indazolhydrochloride (1:1.1) (FFC14A) in patients with solid tumors - a CESAR study

Connexin26 and -30 in the Cochlea and their clinical relevance

Connexin26 und -30 im Innenohr und ihre klinische Bedeutung

Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years

Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial

Correction to: Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years

Cortico-cortical coupling in Parkinson's disease and its modulation by therapy

Three-dimensional study of compressed gas diffusion layers using synchrotron X-ray imaging

Isotopenpraxis

In situ analysis of damage evolution in an Al/[Formula omitted] MMC under tensile load by synchrotron X-ray refraction imaging

The agony of choice in dermatophyte diagnostics—performance of different molecular tests and culture in the detection of Trichophyton rubrum and Trichophyton interdigitale

Dopamine depletion increases the power and coherence of β-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat

Event‐related beta desynchronization in human subthalamic nucleus correlates with motor performance

The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease

Suchergebnisse filtern